Chemistry: analytical and immunological testing – Pregnancy or ovulation
Reexamination Certificate
2007-04-03
2007-04-03
Le, Long V. (Department: 1641)
Chemistry: analytical and immunological testing
Pregnancy or ovulation
C435S007100, C435S007500, C435S007920, C435S007940, C436S501000, C436S518000, C436S524000, C436S528000, C436S065000, C436S811000, C436S547000, C436S548000, C530S387500, C530S388240, C530S389200
Reexamination Certificate
active
09630215
ABSTRACT:
The present invention provides a method of predicting pregnancy outcome in a subject by determining the amount of an early pregnancy associated molecular isoform of hCG in a sample. The present invention further provides a method for determining the amount of early pregnancy associated molecular isoforms of human chorionic gonadotropin (hCG) in a sample. The present invention also provides a diagnostic kit for determining the amount of early pregnancy associated hCG in a sample. The present invention additionally provides an antibody which specifically binds to an early pregnancy associated molecular isoform of human chorionic gonadotropin. Finally, the present invention provides methods for detecting trophoblast or non-trophoblast malignancy in a sample.
REFERENCES:
patent: 4514505 (1985-04-01), Canfield et al.
patent: 5260421 (1993-11-01), Chappel et al.
patent: 6133048 (2000-10-01), Penfold et al.
patent: 6339143 (2002-01-01), Krichevsky et al.
patent: 6429018 (2002-08-01), Cole et al.
patent: 6500627 (2002-12-01), O'Connor et al.
patent: 2003/0022381 (2003-01-01), Pandian et al.
patent: WO-88/04479 (1988-06-01), None
patent: WO9941584 (1999-08-01), None
patent: WO0070094 (2000-11-01), None
Knight, P., “The Carbohydrate Frontier”, BIO/TECHNIQUES, 7(1):35-36, 39-40, Jan. 1989.
Birken et al., (1 993) Separation ofNicked Human Chorionic Gonadotropin (hCG), Intact.
Bogart et al., (1989) “Human Chorionic Gonadotropin Levels in Pregnancies with Aneuploid Fetuses”,Prenat.Diagn. 9: 379-384.
Bogart et al., (1987) “Abnormal Maternal Serum Chorionic Gonadotropin Levels in Pregnancies with Fetal Chromosome Abnormalities”,Prenat.Diagn. 7: 623-630.
Cole et al., (1997) “Oligosaccharide Variants of hCG-related Molecules: Potential Screening Markers for Down Syndrome”,Prenat.Diagn. 17: 1188-1190.
Cole et al., (1998) “Hyperglycosylated hCG, A Potential Alternative To hCG in Down Syndrome Screening”,Prenat.Diagn. 18: 926-933.
Cole et al., (1997) “Urine β-Core Fragment, a Potential Screening Test for Ectopic Pregnancy and Spontaneous Abortion”,Fetal.Diagn. Ther. 12: 336-339.
Forest et al., (1995) “Screening for Down Syndrome During the First and Second Trimesters: Impact of Risk Estimation Parameters”,Clin.Biochem. 28: 443-449.
Kovalevskaya et al., (1999) “Early Prenancy Human Chorionic Gonadotropin (hCG) Isoforms Measured By An Immunometric Assay For Choriocarcinoma-like hCG”,J.Endocrinol. 161: 99-106.
Spencer et al., (1996) “Urine Free beta-hCG and Beta Core in Pregnancies Affected by Down's Syndrome”,Prenat.Diagn. 16: 605-613.
Spencer et al., (1993) “Stability of Intact Chorionic Gonadotropin (hCG) in Serum, Liquid Whole Blood, and Dried Whole-Blood Filter-Paper Spots: Impact on Screening for Down Syndrome by Measurment of Free β-hCG Subunit”,Clin.Chem. 39: 1064-1068.
Spencer et al., (1997) “Biochemical Markers of Trisomy 21 in Amniotic Fluid”,Prenat.Diagn. 17: 31-37.
Valerio et al., (1996) “Maternal Serum Screening of Fetal Chromosomal Abnormalities by AFP. UE3, hCG and free-βhCG”,Minerva.Ginecol. 48: 169-173.
Wald et al.,(1994) “Four-Marker Serum Screening For Down's Syndrome”,Prenat.Diagn. 14: 707-716.
Birken et al., (1996) “Isolation and Characterization of Human Pituitary Chorionic Gonadotropin”,Endocrinology137: 1402-1411.
Cole et al., (1993) “The Deactivation of hCG by Nickling and Dissociation”,J.Clin.Endocrinol.Metab. 76: 704-710.
Cole et al., (1985) “The Structures of the Serine-linked Sugar Chains on Human Chorionic Gonadotropin”,Biochem.Biophys.Res.Commun. 126: 333-339.
Ellish et al., (1996) “A Prospective Study of Early Pregnancy Loss”,Hum.Reprod. 11: 406-412.
Hoermann et al., (1994) “Immunological Recognition and Clinical Significance of Nicked Human Chorionic Gonadotropin in Testicular Cancer”,Clin.Chem. 40: 2306-2312.
Kovalevskaya et al., (1995) “HLH Beta Core Fragment Immunoreactivity in the Urine of Ovulating Women: A Sensitive and Specific Immunometric Assay for its Detection”,Endocrine3: 881-887.
O'Connor et al., (1994) “Recent Advances in the Chemistry and Immunochemistry of Human Chorionic Gonadotropin: Impact on Clinical Measurements”,Endocr.Rev. 15: 650-683.
O'Connor et al., (1998) “Differential Urinary Gonadotropin Profiles in Early Pregnancy and Early Pregnancy Loss”,Prenat.Diagn.18: 1232-1240.
O'Connor et al., (1988) “Development of Highly Sensitive Immunoassays to Measure Human Chorionic Gonadotropin, its Beta-subunit, and Beta Core Fragment in the Urine: Application to Malignancies”,Cancer Res. 48: 1361-1366.
Wilcox et al., (1988) “Incidence of Early Loss of Pregnancy”,N.Engl.J.Med. 319: 189-194.
Zinaman et al., (1996) “Estimates of Human Fertility and Pregnancy Loss”,Fertil.Steril. 65: 503-509.
Acevedo et al., (1992) “Expression of Membrane-associated Human Chorionic Gonadotropin, Its Subunits, and Fragments by Cultured Human Cancer Cells”,Cancer69(7): 1829-1842.
Berger et al., (1993) “Variants of Human Chorionic Gonadotropin from Pregnant Women and Tumor Patients Recognized by Monoclonal Antibodies”,J. Clin. Endocrinol. and Metabolism77(2); 347-351.
Birken et al., (1999) “Development and Characterization of Chorionic Gonadotropin in Serum and Urine from Patients with Trophoblastic Tumors”,Clinical Investigation71: 953-960.
Cole et al., (1991) “The Heterogeneity of Human Chorionic Gonadotropin (hCG). III. The Occurrence and Biological and Immunological Activites of Nicked hCG”,Endocrinology129(3): 1559-1567.
Hoermann et al., (1993) “Molecular Heterogeneity of Human Chorionic Gonadotropin in Serum and Urine from Patients with Trophoblastic Tumors”,Clinical Investigation71: 953-960.
Kovalevskaya et al., (1999) “Evaluation of Nicked Human Chorionic Gonadotropin Content in Clinical Specimens by a Specific Immunometric Assay”,Clinical Chemistry45(1):68-77.
Birken et al., (1993) “Separation of Nicked Human Chorionic Gonadotropin (hCG), Intact hCG, and hCGβ Fragment from Standard Reference Preparations and Raw Urine Samples”,Endocrinology133(3): 1390-1397.
Ellish et al., (1996) “A Prospective Study of Early Pregnancy Loss”,Human Reproduction11(2); 407-408.
Hoermann et al., (1994) “Immunological Recognition and Clinical Significance of Nicked Human Chorionic Gonadotropin in Testicular Cancer”Clinical Chemistry40(12): 2306-2312.
Knight, (1989) “The Carbohydrate Frontier”,Biotechnology7(1): 35 and 39-40.
O'Connor et al., (1988) “Development of Highly Sensitive Immunoassays to Measure Human Chorionic Gonadotropin, Its β-subunit, and Core Fragment in Urine: Application to Malignancies”,Cancer Research38: 1361-1366.
European Search Report dated Nov. 20, 2002 (Exhibit 5).
Ehrlich P.H. and Moyle W.R. (1983) “Cooperative immunoassays: ultrasensitive assays with mixed monoclonal antibodies,” Science 221:279-81 (Exhibit 6).
Ehrlich P.H. et al. (1982) “Mixing two monoclonal antibodies yields enhanced affinity for antigen,” J. Immunol. 128 (6) :2709-13 (Exhibit 7).
Ehrlich P.H. et al. (1985) “Characterization and relative orientation of epitopes for monoclonal antibodies and antisera to human chorionic gonadotropin,” Am. J. Reprod. Immunol. Microbiol. 8 (2) :48-54 (Exhibit 8).
Ehrlich P.H. et al. (1985) “Monoclonal antibodies to gonadotropin subunits,” Methods Enzymol. 109:638-55 (Exhibit 9).
Elliott, M.M. et al. (1997) “Carbohydrate and peptide structure of the alpha and beta-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma,” Endocrine 7 (1) :15-32 (Exhibit 10).
Kardana, A. et al. (1991) “The heterogeneity of human chorionic gonadotropin (hCG) . I
Birken Steven
Kovalevskaya Galina I.
O'Connor John F.
Cooper & Dunham LLP
Gabel Gailene R.
Le Long V.
The Trustees of Columbia University in the City of New York
White, Esq. John P.
LandOfFree
Methods for predicting pregnancy outcome in a subject by hCG... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for predicting pregnancy outcome in a subject by hCG..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for predicting pregnancy outcome in a subject by hCG... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3791306